Imp-1-producing carbapenem-resistant acinetobacter ursingii from Japan

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 10, 2012, Pages 2533-2534

  Endo, Shiro ^a   Sasano, Mina ^a   Yano, Hisakazu ^a   Inomata, Shinya ^a   Ishibashi, Noriomi ^a   Aoyagi, Tetsuji ^a   Hatta, Masumitsu ^a   Gu, Yoshiaki ^a   Yamada, Mitsuhiro ^a   Tokuda, Koichi ^a   Kitagawa, Miho ^a   Kunishima, Hiroyuki ^a   Hirakata, Yoichi ^a   Kaku, Mitsuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acinetobacter spp.; Bacteraemia; CarO; IMP 1; OXA 58

Indexed keywords

CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN;

ACINETOBACTER; ACINETOBACTER INFECTION; ACINETOBACTER URSINGII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AORTA ANEURYSM; AORTA RECONSTRUCTION; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CASE REPORT; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; ENDOTRACHEAL TUBE; HEMODIALYSIS; HUMAN; HYPERTENSION; JAPAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OROPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; THORAX DRAINAGE; URETHRAL CATHETER;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 84866618765     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks249     Document Type: Letter

References (8)

1. Karah N, Haldorsen B, Hegstad K et al. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother 2011; 66: 738-44.
2. Horii T, Tamai K, Mitsui M et al. Bloodstream infections caused by Acinetobacter ursingii in an obstetrics ward. Infect Genet Evol 2011; 11: 52-6.
3. La Scola B, Gundi VA, Khamis A et al. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006; 44: 827-32.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
5. Espinal P, Fugazza G, López Y et al. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother 2011; 55: 5396-8.
6. Poirel L, Nordmann PG. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 1442-8.
7. Park YK, Jung SI, Park KH et al. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Int J Antimicrob Agents 2012; 39: 81-5.
8. Lee YC, Huang YT, Tan CK et al. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob Chemother 2011; 66: 1839-46.